Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gain Therapeutics, Inc.

1.74
+0.01000.58%
Post-market: 1.740.00000.00%19:41 EDT
Volume:111.71K
Turnover:192.67K
Market Cap:51.43M
PE:-2.13
High:1.81
Open:1.77
Low:1.66
Close:1.73
Loading ...

Gain Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Gain Therapeutics reports FY24 EPS (89c), consensus ($1.00)

TIPRANKS
·
27 Mar

Press Release: Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update

Dow Jones
·
27 Mar

Gain Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
21 Mar

Analysts Offer Insights on Healthcare Companies: 89bio (ETNB), Gain Therapeutics (GANX) and Boston Scientific (BSX)

TIPRANKS
·
20 Mar

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Mar

Gain Therapeutics doses first participant in Phase 1b trial of GT-02287

TIPRANKS
·
14 Mar

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

GlobeNewswire
·
14 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

Gain Therapeutics Announces Oral Presentation at AD/PD 2025

GlobeNewswire
·
06 Mar

Gain Therapeutics Advances GT-02287 in Parkinson’s Trials

TIPRANKS
·
07 Feb

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

THOMSON REUTERS
·
06 Feb

Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update

GlobeNewswire
·
06 Feb

Gain Therapeutics To Participate in Upcoming Investor Conferences

GlobeNewswire
·
05 Feb

All You Need to Know About Gain Therapeutics (GANX) Rating Upgrade to Strong Buy

Zacks
·
17 Jan

BRIEF-Gain Therapeutics Forms Clinical Advisory Board To Support Continued Advancement Of Lead Drug Candidate GT-02287

Reuters
·
08 Jan

Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

THOMSON REUTERS
·
08 Jan

Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

GlobeNewswire
·
08 Jan

Gain Therapeutics Appoints New CEO Amidst Clinical Progress

TIPRANKS
·
08 Jan

Gain Therapeutics appoints Mack as CEO, Director

TIPRANKS
·
07 Jan